Momin, Noor http://orcid.org/0000-0003-3145-6089
Palmeri, Joseph R. http://orcid.org/0000-0002-3932-9124
Lutz, Emi A. http://orcid.org/0000-0002-7649-4241
Jailkhani, Noor
Mak, Howard
Tabet, Anthony
Chinn, Magnolia M. http://orcid.org/0000-0002-0356-195X
Kang, Byong H. http://orcid.org/0000-0002-1637-2082
Spanoudaki, Virginia
Hynes, Richard O. http://orcid.org/0000-0001-7603-8396
Wittrup, K. Dane http://orcid.org/0000-0003-2398-5896
Funding for this research was provided by:
NSF | Directorate for Education & Human Resources | Division of Graduate Education
NSF | Directorate for Education & Human Resources | Division of Graduate Education
NSF | Directorate for Education & Human Resources | Division of Graduate Education
U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute (P30-CA14051, P30-CA14051)
NSF | Directorate for Education & Human Resources | Division of Graduate Education
Paul and Daisy Soros Fellowships for New Americans
U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute
U.S. Department of Defense (W81XWH-14–1-0240)
Article History
Received: 19 June 2021
Accepted: 17 November 2021
First Online: 10 January 2022
Competing interests
: N.M., J.R.P., M.M.C., and K.D.W. are inventors on U.S. Provisional Patent application no. 62/738,981 regarding collagen-anchoring immunomodulatory molecules and methods thereof. Cullinan Oncology is the assignee of this patent application. K.D.W. and N.M are consultants/advisors for Cullinan Oncology. N.J. and R.O.H. are inventors on U.S. Provisional Patent application no. 62/621,811 regarding nanobody based imaging and targeting of the extracellular matrix in disease and development. Massachusetts Institute of Technology is the assignee of this patent application. The remaining authors report no competing interests.